Urolithin A induces prostate cancer cell death in p53-dependent and in p53-independent manner

A review of pomegranate in prostate cancer

(2017) C J Paller et al.   PROSTATE CANCER AND PROSTATIC DISEASES

Urolithin A causes p21 up-regulation in prostate cancer cells

(2015) Claudia Sánchez-González et al.   EUROPEAN JOURNAL OF NUTRITION

Anandamide-induced endoplasmic reticulum stress and apoptosis are mediated by oxidative stress in non-melanoma skin cancer: Receptor-independent endocannabinoid signaling

(2015) Eman Soliman et al.   MOLECULAR CARCINOGENESIS

Androgen receptor signaling in prostate cancer

(2014) Zoran Culig et al.   CANCER AND METASTASIS REVIEWS

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Drugging the p53 pathway: understanding the route to clinical efficacy

(2014) Kian Hoe Khoo et al.   NATURE REVIEWS DRUG DISCOVERY

Critical role for p53-serine 15 phosphorylation in stimulating transactivation at p53-responsive promoters

(2014) Jayne Loughery et al.   NUCLEIC ACIDS RESEARCH

Walnut polyphenol metabolites, urolithins A and B, inhibit the expression of the prostate-specific antigen and the androgen receptor in prostate cancer cells

(2014) Claudia Sánchez-González et al.   Food & Function

A Walnut-Enriched Diet Reduces the Growth of LNCaP Human Prostate Cancer Xenografts in Nude Mice

(2013) Russel J. Reiter et al.   CANCER INVESTIGATION

Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model

(2013) N. Khan et al.   CARCINOGENESIS

Biological Significance of Urolithins, the Gut Microbial Ellagic Acid-Derived Metabolites: The Evidence So Far

(2013) Juan Carlos Espín et al.   Evidence-based Complementary and Alternative Medicine

Pomegranate Juice Metabolites, Ellagic Acid and Urolithin A, Synergistically Inhibit Androgen-Independent Prostate Cancer Cell Growth via Distinct Effects on Cell Cycle Control and Apoptosis

(2013) Roberto Vicinanza et al.   Evidence-based Complementary and Alternative Medicine

The degradation of p53 and its major E3 ligase Mdm2 is differentially dependent on the proteasomal ubiquitin receptor S5a

(2013) A Sparks et al.   ONCOGENE

p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3

(2012) William H. Chappell et al.   CELL CYCLE

Green Tea Polyphenols Induce p53-Dependent and p53-Independent Apoptosis in Prostate Cancer Cells through Two Distinct Mechanisms

(2012) Karishma Gupta et al.   PLoS One

A p53-independent role for the MDM2 antagonist Nutlin-3 in DNA damage response initiation

(2011) Jane M Valentine et al.   BMC CANCER

Acetylation is indispensable for p53 antiviral activity

(2011) Cesar Muñoz-Fontela et al.   CELL CYCLE

Ellagitannins, ellagic acid and their derived metabolites: A review about source, metabolism, functions and health

(2011) J.M. Landete   FOOD RESEARCH INTERNATIONAL

USP10 Regulates p53 Localization and Stability by Deubiquitinating p53

(2010) Jian Yuan et al.   CELL

Angiogenesis as a potential target of pharmaconutrients in cancer therapy

(2010) Virginie Granci et al.   CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE

p53 post-translational modification: deregulated in tumorigenesis

(2010) Chao Dai et al.   TRENDS IN MOLECULAR MEDICINE

Regulation of XIAP Translation and Induction by MDM2 following Irradiation

(2009) Lubing Gu et al.   CANCER CELL

Modes of p53 Regulation

(2009) Jan-Philipp Kruse et al.   CELL

The multiple levels of regulation by p53 ubiquitination

(2009) J T Lee et al.   CELL DEATH AND DIFFERENTIATION

PHELLODENDRON AMURENSE BARK EXTRACT ENHANCES RADIOSENSITIVITY BY INHIBITION OF NF-KAPPA B IN TRANSGENIC ADENOCARCINOMA OF MOUSE PROSTATE MODEL AND HUMAN PROSTATE CANCER CELLS

(2009) Craig H Robson et al.   JOURNAL OF UROLOGY

Hydroxytyrosol inhibits the proliferation of human colon adenocarcinoma cells through inhibition of ERK1/2 and cyclin D1

(2009) Giulia Corona et al.   MOLECULAR NUTRITION & FOOD RESEARCH

SnapShot: p53 Posttranslational Modifications

(2008) Jan-Philipp Kruse et al.   CELL

Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation

(2008) Sanjeev Shukla et al.   FREE RADICAL BIOLOGY AND MEDICINE

Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study

(2008) Dominik R. Berthold et al.   JOURNAL OF CLINICAL ONCOLOGY